Subjects:Fifty-four (54) participants, 65 or older (mean 73.5 years), without clinical signs of dementia, were re- cruited and randomized to Bacopaor placebo. Forty-eight (48) completed the study with 24 in each group.
Subjects:Fifty-four (54) participants, 65 or older (mean 73.5 years), without clinical signs of dementia, were re- cruited and randomized to Bacopaor placebo. Forty-eight (48) completed the study with 24 in each group.